Chinese Journal of Tissue Engineering Research ›› 2022, Vol. 26 ›› Issue (24): 3785-3789.doi: 10.12307/2022.554

Previous Articles     Next Articles

Osteoblast differentiation after conditional knockout of 3-phosphoinositide-dependent protein kinase-1 gene from bone marrow mesenchymal stem cells

Chen Qiaoling1, Bai Yiguang2, Liu Kang3, Lin Tao2, Luo Xuwei2   

  1. 1Department of Oncology, 2Department of Orthopedics, 3Institute of Tissue Engineering and Stem Cells, Second Clinical Institute of North Sichuan Medical College• Nanchong Central Hospital, Nanchong 637000, Sichuan Province, China
  • Received:2021-04-28 Accepted:2021-08-09 Online:2022-08-28 Published:2022-01-22
  • Contact: Bai Yiguang, MD, Attending physician, Department of Orthopedics, Second Clinical Institute of North Sichuan Medical College• Nanchong Central Hospital, Nanchong 637000, Sichuan Province, China
  • About author:Chen Qiaoling, MD, Associate chief physician, Department of Oncology, Second Clinical Institute of North Sichuan Medical College• Nanchong Central Hospital, Nanchong 637000, Sichuan Province, China
  • Supported by:
    Project of Sichuan Health and Family Planning Commission, No. 16PJ202 (to BYG); Nanchong University Science and Technology Strategic Cooperation Project, No. 18SXHZ0539 (to BYG)

Abstract: BACKGROUND: The research on 3-phosphoinositide-dependent protein kinase-1 (PDK-1) in and outside China is mainly concentrated in endocrinology and oncology. There are no systematic studies and reports on its influence on osteogenic differentiation in orthopedics.
OBJECTIVE: To observe the role of PDK-1 in osteoblast differentiation by transfecting PDK-1flox/flox mouse bone marrow mesenchymal stem cells with adenovirus stably expressing cre enzyme (pHBAd-cre-EGFP). 
METHODS: Bone marrow mesenchymal stem cells from homozygous PDK-1flox/flox mice were obtained and cultured in vitro. A control group, an empty virus group (pHBAd-EGFP) and a pHBAd-cre-EGFP group were set. In the control group, osteoblast induction medium was used to induce bone marrow mesenchymal stem cells. In pHBAd-EGFP group, pHBAd-EGFP was used to transfect bone marrow mesenchymal stem cells. In the pHBAd-cre-EGFP group, the recombinant adenovirus containing Cre recombinant enzyme (pHBAd-cre-EGFP) was used to transfect with the PDK-1 gene in bone marrow mesenchymal stem cells followed by osteogenic induction. Alkaline phosphatase staining, alkaline phosphatase activity assay, alizarin red staining, and qPCR were used to detect osteogenesis-related gene expression and to evaluate the differentiation and maturation of osteoblasts. 
RESULTS AND CONCLUSION: The alkaline phosphatase secretion, alkaline phosphatase activity, and the ability of cell mineralization in the pHBAd-cre-EGFP group were significantly lower than those in the other two groups (P < 0.05, P < 0.01), and the expression levels of Runx2, osteocalcin, and collagen I were also significantly lower than those in the other two groups (P < 0.01). The results have confirmed that interference with PDK-1 gene in vitro can significantly inhibit the osteogenic differentiation of bone marrow mesenchymal stem cells. 

Key words: metastatic bone tumor, osteoporosis, bone destruction, osteoblasts, PDK-1, signaling pathway

CLC Number: